Other Clinical Trial - Portable Ultrasound for Interventional Procedures

Status Not yet recruiting

Clinical Trial Summary

We are evaluating whether a portable ultrasound can be safely and effectively used in portable interventional procedures, whether the image quality can be improved to meet standard existing ultrasounds. In the COVID-19 pandemic, transferring patients with COVID-19 to the procedure room results in contamination and shut down of those rooms while also putting folks in transit at some degree of transmission risk. The ability to do procedures at bedside can alleviate those risks greatly.

Clinical Trial Description

Portable ultrasound-guided procedures, including paracentesis, thoracentesis, drain placement, or simple biopsies can be required for patients who are difficult to move, in particular COVID-19 patients, patients in the ICU, or on the floor. Portable ultrasounds have demonstrated a convenient ability to provide a point of care ultrasound diagnostic testing with expanding use in standard clinical care. A number of portable ultrasound systems are in routine clinical use at MGH and have been used for diagnostic procedures (e.g. Butterfly, Hologic, others). Most of the systems are still tethered (transducer is connected via cables to a computer or power) which may represent challenges for contamination, especially in interventional procedures. The Healcerion system is the first FDA approved wireless and battery-operated portable ultrasound system of its kind and is in routine use for diagnostic ultrasounds throughout the world. The goal of the current study is to compare the utility and practical operations of the advanced Healcerion SONON ultrasound system to a standard wheeled and bulky ultrasound systems in current use (Hitachi, GE). While the Healcerion device has been used at other institutions, it has not been used for interventional procedures at MGH. A comparative efficacy study will allow the investigators to examine the safety and efficacy of the device to complete procedures in a portable setting as well as explore whether images can be improved to reach the more robust imaging capability of wired devices. ;

Study Design

Related Conditions & MeSH terms

Ultrasound Therapy; Complications

Clinical Trial Details

NCT number	NCT04685330
Study type	Observational
Source	Massachusetts General Hospital
Contact	Avik Som, MD
Phone	+1-832-330-7557
Email	Avik.Som@MGH.HARVARD.EDU
Status	Not yet recruiting
Phase
Start date	January 1, 2021
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04659395` - How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block	N/A
Recruiting	`NCT04438265` - Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
Recruiting	`NCT04952220` - Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee
Completed	`NCT04149041` - The Applications of Point-of-care Ultrasound in ED Unselected, Non-critical Patients
Completed	`NCT06000215` - Credibility of Ultrasound Detection of Female Genital Prolapse Mesh
Completed	`NCT04581616` - The Effect of Ultrasound-guided Erector Spinae Block and Intraoperative Intercostal Nerve Block on Postoperative Analgesia in Thoracic Surgery	N/A
Completed	`NCT05151432` - Effect of Pulsed Electromagnetic Field and Pulsed Ultrasound in Treating Knee Osteoarthritis	N/A
Completed	`NCT04674852` - Mayo Designed Soft Tissue Ultrasound-Detectable Marker	N/A
Recruiting	`NCT05627830` - Ultrasound Guided Versus Non-Guided Prolotherapy for Internal Derangement of Temporomandibular Joint.	N/A
Completed	`NCT04382430` - Ultrasound Axillary Vein Access: Evaluation of Learning Curve for an Alternative Approach to Cardiac Device Implantation	N/A
Completed	`NCT04917406` - Effect of Iontophoresis vs. Ultrasound and Iontophoresis in Plantar Fasciitis". Plantar Fasciitis"	N/A
Not yet recruiting	`NCT04862182` - Intrapartum Ultrasound in Predicting Mode of Delivery
Completed	`NCT03122119` - Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint	Phase 4
Completed	`NCT04753450` - Correlation of Muscle Ultrasound Measures (2D and 3D) With Biphotonic X-ray Absorptiometry in Oldest Old Patients.
Completed	`NCT03676699` - Lung Ultrasound in Detection of Extravascular Lung Water in Septic Patients.
Recruiting	`NCT03144895` - Arterial Catheterization by Ultrasound	N/A
Recruiting	`NCT05535816` - Accuracy of Ultrasound for Detecting Residual Fragments During RIRS	N/A
Recruiting	`NCT05769517` - PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES
Completed	`NCT05927285` - Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1	N/A
Recruiting	`NCT04828746` - Utility of Ultrasound-Guided Site Marking in Pediatric Lumbar Punctures	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.